Biontech Expects At Least 17 Data Publications From Clinical Trials In Late-Stage Development Over Next Five Years

Reuters
Jan 12
Jan 12 (Reuters) - BIONTECH SE <22UAy.DE>::
*EXPECTS AT LEAST 17 DATA PUBLICATIONS FROM CLINICAL TRIALS IN LATE-STAGE DEVELOPMENT OVER NEXT FIVE YEARS
*ONCOLOGY: PLANS START OF 6 FURTHER PHASE 3 CLINICAL TRIALS IN 2026
*COULD BECOME A MULTI-PRODUCT ONCOLOGY COMPANY BY 2030 IF DATA FROM CLINICAL TRIALS IS POSITIVE
*Further company coverage: [22UAy.DE]
* (Gdansk Newsroom)
* ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 12-JAN-202611:44:51 GMT

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10